MET and cancer: About 13 genes such as MET, ITGA3, ITGA2, LAMA3, and SLC2A1 are predicted to be involved in multiple cancer-related pathways such as ECM–receptor interaction, small cell lung cancer, FA, central carbon metabolism in cancer, pathways in cancer, PI3K-Akt signaling pathway, renal cell carcinoma, and HIF-1 signaling pathway.